Get started
Author

Abdulmelik Aytatlı

Observed names: Abdulmelik AYTATLİ, Abdulmelik Aytatli, Abdülmelik Aytatlı
Observed institution: Erzurum Technical University
ORCID: 0000-0002-9204-1234
Observed ORCID: 0000-0002-9204-1234
OpenAlex ID: A5063044217
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
2021 · Abdulmelik Aytatli, Neslisah Barlak, et al. · Cellular Oncology · 23
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer
2019 · Neslisah Barlak, Ozel Capik, et al. · Cell Biology International · 21
Synthesis and Computational Evaluation of N-Acetyl-Derived Schiff Bases Incorporating 1,2,4-Triazoles for Dual Inhibition of Prostate Cancer Cells and Carbonic Anhydrases
2025 · Hilal Medetalibeyoğlu, Abdulmelik Aytatlı, et al. · ACS Omega · 16
PDF
Mode of action of carboplatin via activating p53/miR‐145 axis in head and neck cancers
2019 · Ahsen Kilic, Neslisah Barlak, et al. · The Laryngoscope · 13
Design, synthesis, and biological evaluation of indole-modified tamoxifen relatives as potent anticancer agents
2023 · Berrak Ertugrul, Abdulmelik Aytatli, et al. · RSC Medicinal Chemistry · 11
PDF
MicroRNA‐145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells
2021 · Neslisah Barlak, Ozel Capik, et al. · Cell Biology International · 11
Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer
2024 · Hasan Onur Caglar, Abdulmelik Aytatli, et al. · Head & Neck · 6
PDF
Curcumin as an Epigenetic Modulator: Suppression of Breast Cancer via the Hsa_circ_0001946/MiR-7-5p/Target Gene Axis
2025 · Asmaa Abuaisha, Murat Kaya, et al. · Medicina · 2
PDF
CDR1as/miR-7-5p/ IGF1R axis contributes to the suppression of cell viability in prostate cancer
2024 · Murat Kaya, Ilknur Suer, et al. · Turkish Journal of Biochemistry · 2
PDF
In silico identification of differentially expressed microRNAs in thyroid cancer
2024 · Hasan Onur Caglar, Abdulmelik Aytatli, et al. · Human Gene · 2
Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer
2026 · Abdulmelik Aytatli, Abdulkadir Sahin, et al. · Endocrine · 1
PDF
The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells
2020 · Fatma Şanlı, Neslişah Barlak, et al. · The European Research Journal · 1
Tamoxifen‐Based Dimers: Design, Synthesis, Cell Viability Evaluation on Breast Cancer Cells, and Computational Insights
2026 · Berrak Ertugrul, Abdulmelik Aytatli, et al. · Archiv der Pharmazie
Kodlamayan RNA’lar
2023 · Abdulmelik Aytatlı, Ömer Faruk Karataş · Akademisyen Kitabevi eBooks
Current Cancer Stem Cell Biomarkers in Tongue Squamous Cell Carcinoma
2018 · Omer Faruk KARATAS, Seyma TEBER, et al. · Trakya University Journal of Natural Sciences
PDF
Works count: 15
Citation count: 109
H-index: 6
I10-index: 6
Year
Topic
Type